Plunkett Research Online: Veloxis Pharmaceuticals AS

VELOXIS PHARMACEUTICALS AS (LFCYF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Veloxis Pharmaceuticals AS is a commercial-stage specialty pharmaceutical company. It develops products and technology to improve the lives of transplant patients. The firm's products and technology include envarsus xr and fenoglide and meltdose technology.The company is focused on the direct commer.....



Veloxis Pharmaceuticals AS
Ticker: LFCYF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 45 70333300
Fax:
Address: Amerika Plads 37
København Ø, 2100 Denmark

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Veloxis Pharmaceuticals AS is a commercial-stage specialty pharmaceutical company. It develops products and technology to improve the lives of transplant patients. The firm's products and technology include envarsus xr and fenoglide and meltdose technology.The company is focused on the direct commer.....See More See More

Auditor: PricewaterhouseCoopers
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: